U.S. Rep. Conor Lamb, D-Mt. Lebanon, last week called on the Centers for Medicare & Medicaid Services, which oversees nursing homes, and the U.S. Department of Health & Human Services to look into Brighton’s use of hydroxycholoroquine.
“At this point, the Pennsylvania Department of Health does not appear to have imposed any accountability or punishment on Brighton for the use of hydroxychloroquine without permission,” Lamb said.
Sens. Pat Toomey, R-Lehigh Valley, and Bob Casey, D-Scranton, also have called for a federal probe into reports of the distribution of hydroxychloroquine.
Health department officials said last week they “will continue to follow the legal processes set forth in federal and state statutes and regulations” in its oversight of nursing homes.
A corrective plan that is part of the state report indicates Brighton no longer is administering the drug and that the medical director and clinical leaders were required by July 7 to undergo training in patient rights in regard to experimental research. Audits will be performed to ensure the Brighton officials have complied, records show.
Hydroxychloroquine is not approved by the U.S. Food and Drug Administration as a treatment for the coronavirus but had been administered as an emergency, experimental treatment for covid-19, the disease caused by the coronavirus. The FDA revoked that emergency authorization June 15.
Brighton officials defended the use of the drug.
“Since the onset of covid-19, Brighton has followed the guidance of government health care officials and physicians,” a statement signed by Brighton Facility Management said. “Like any drug, hydroxychloroquine would have to be prescribed by a treating physician. Facility staff only assist with administering medications.”
The statement went on to say the treatment was prescribed following the FDA emergency use authorization issued in March “with the full consent of residents and/or their legal guardians.”
“After the FDA revoked the (emergency authorization), physicians immediately ended this practice and ceased prescribing it,” the statement said.
"use" - Google News
August 09, 2020 at 06:32PM
https://ift.tt/2EXzt4v
Brighton Rehab under scrutiny for hydroxychloroquine use to thwart coronavirus - TribLIVE
"use" - Google News
https://ift.tt/2P05tHQ
https://ift.tt/2YCP29R
Bagikan Berita Ini
0 Response to "Brighton Rehab under scrutiny for hydroxychloroquine use to thwart coronavirus - TribLIVE"
Post a Comment